Literature DB >> 16166619

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.

Moises Selman1, Annie Pardo, Lourdes Barrera, Andrea Estrada, Susan R Watson, Keith Wilson, Natasha Aziz, Naftali Kaminski, Albert Zlotnik.   

Abstract

RATIONALE: Many of the interstitial lung diseases represent a diagnostic and therapeutic challenge because their clinical and even histologic features are often nonspecific. Likewise, the transcriptional signatures of most of them are unknown.
OBJECTIVE: To compare the gene expression patterns from patients with idiopathic pulmonary fibrosis (IPF) hypersensitivity pneumonitis (HP), and nonspecific interstitial pneumonia (NSIP) using custom oligonucleotide microarrays.
METHODS: We profiled lung biopsies from 15 patients with IPF, 12 with HP, and eight with NSIP. Labeled complementary ribonucleic acid was hybridized to a custom Affymetrix oligonucleotide DNA microarray using standard Affymetrix protocols. The custom array, Hu03, contained 59,619 probe sets representing an estimated 46,000 gene clusters.
RESULTS: We identified statistically significant gene expression signatures that characterize HP and IPF. The HP gene expression signature was enriched for genes that are functionally associated with inflammation, T-cell activation, and immune responses, whereas the IPF signature was characterized by the expression of tissue remodeling, epithelial, and myofibroblast genes. We then compared these gene expression signatures to classify NSIP, a histologic pattern that is often difficult to differentiate consistently from HP and IPF. Two cases exhibited an IPF-like gene expression, another one could be more properly classified as HP, whereas others did not resemble HP or IPF, suggesting that they may represent idiopathic NSIP.
CONCLUSIONS: Our results underscore the value of gene expression signatures to classify the interstitial lung diseases and to understand pathogenic mechanisms, and suggest new ways to improve the diagnosis and treatment of patients with these diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16166619      PMCID: PMC2662988          DOI: 10.1164/rccm.200504-644OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  57 in total

1.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase.

Authors:  Fei Su; Michael Overholtzer; Daniel Besser; Arnold J Levine
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

3.  Histopathologic variability in usual and nonspecific interstitial pneumonias.

Authors:  K R Flaherty; W D Travis; T V Colby; G B Toews; E A Kazerooni; B H Gross; A Jain; R L Strawderman; A Flint; J P Lynch; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

4.  Tissue classification with gene expression profiles.

Authors:  A Ben-Dor; L Bruhn; N Friedman; I Nachman; M Schummer; Z Yakhini
Journal:  J Comput Biol       Date:  2000       Impact factor: 1.479

5.  Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease.

Authors:  A Camarena; A Juárez; M Mejía; A Estrada; G Carrillo; R Falfán; J Zuñiga; C Navarro; J Granados; M Selman
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

Review 6.  Hypersensitivity pneumonitis: current concepts and future questions.

Authors:  A M Patel; J H Ryu; C E Reed
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

7.  Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease.

Authors:  A Ramírez-Venegas; R H Sansores; R Pérez-Padilla; G Carrillo; M Selman
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

8.  Epitope-defined monoclonal antibodies against multiplexin collagens demonstrate that type XV and XVIII collagens are expressed in specialized basement membranes.

Authors:  Yasuko Tomono; Ichiro Naito; Kaori Ando; Tomoko Yonezawa; Yoshikazu Sado; Satoshi Hirakawa; Jirô Arata; Tohru Okigaki; Yoshifumi Ninomiya
Journal:  Cell Struct Funct       Date:  2002-02       Impact factor: 2.212

Review 9.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

Review 10.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

View more
  165 in total

1.  The role of postmortem studies in pneumonia etiology research.

Authors:  Gareth D H Turner; Charatdao Bunthi; Chizoba B Wonodi; Susan C Morpeth; Catherine S Molyneux; Sherif R Zaki; Orin S Levine; David R Murdoch; J Anthony G Scott
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

2.  Altered DNA methylation profile in idiopathic pulmonary fibrosis.

Authors:  Yan Y Sanders; Namasivayam Ambalavanan; Brian Halloran; Xiangyu Zhang; Hui Liu; David K Crossman; Molly Bray; Kui Zhang; Victor J Thannickal; James S Hagood
Journal:  Am J Respir Crit Care Med       Date:  2012-06-14       Impact factor: 21.405

Review 3.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 4.  Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Authors:  Rachel C Chambers; Paul F Mercer
Journal:  Ann Am Thorac Soc       Date:  2015-03

5.  What is this thing called CFA?

Authors:  A U Wells; D M Hansell; A G Nicholson
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

Review 6.  Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Authors:  Naftali Kaminski; Ivan O Rosas
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 7.  Towards systems biology of human pulmonary fibrosis.

Authors:  Sean M Studer; Naftali Kaminski
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 8.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

9.  Revealing the Secrets of Idiopathic Pulmonary Fibrosis.

Authors:  Richard K Albert; David A Schwartz
Journal:  N Engl J Med       Date:  2019-01-03       Impact factor: 91.245

10.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Authors:  Marco Checa; Víctor Ruiz; Martha Montaño; Rafael Velázquez-Cruz; Moisés Selman; Annie Pardo
Journal:  Hum Genet       Date:  2008-10-14       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.